SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-16-000170
Filing Date
2016-07-06
Accepted
2016-07-06 16:02:32
Documents
12
Period of Report
2016-07-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201607068xkdoc.htm 8-K 27635
2 PRESENTATION pdli-201607068xkex991.htm EX-99.1 4750
3 a070516slide1.jpg GRAPHIC 89043
4 a070516slide2.jpg GRAPHIC 239782
5 a070516slide3.jpg GRAPHIC 105254
6 a070516slide4.jpg GRAPHIC 128280
7 a070516slide5.jpg GRAPHIC 167793
8 a070516slide6.jpg GRAPHIC 101791
9 a070516slide7.jpg GRAPHIC 94308
10 a070516slide8.jpg GRAPHIC 77754
11 a070516slide9.jpg GRAPHIC 91751
12 a070516slide10.jpg GRAPHIC 81984
  Complete submission text file 0000882104-16-000170.txt   1656628
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 161753704
SIC: 2836 Biological Products, (No Diagnostic Substances)